The Relative Oral Bioavailability of a Tablet Formulation vs a Solutionof PLN-74809 in Healthy Participants
Latest Information Update: 25 May 2022
At a glance
- Drugs Bexotegrast (Primary) ; Bexotegrast
- Indications Idiopathic pulmonary fibrosis; Primary sclerosing cholangitis
- Focus Adverse reactions
- Sponsors Pliant Therapeutics
Most Recent Events
- 18 May 2022 According to a Pliant Therapeutics media release, data from this study were presented at the 2022 American Thoracic Society (ATS) International Conference.
- 01 Jul 2019 New trial record
- 27 Jun 2019 Results presented in the Pliant Therapeutics media release.